About BioZyme
BioZyme is a Healthcare company based in Saint Joseph (United States) founded in 1951. Animal feed supplements and additives are manufactured for various species. The company has 74 employees. Its chief executive, as recorded, is Bob Norton. BioZyme offers products and services including VitaFerm, Sure Champ, AO-Biotics, and Amaferm. Its focus areas include Veterinary Health Products. Its legal entity is BIOZYME INCORPORATED. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
BioZyme was founded in 1951 in Saint Joseph, United States, and operates within the animal nutrition sector. Prebiotics and postbiotics are developed and produced from a proprietary strain of Aspergillus oryzae to support digestion, gut health, and well-being in cattle, swine, poultry, and companion animals. Additional feed additives are provided to improve overall nutrition. Research and development efforts are focused on product efficacy and validation of health benefits.
- Headquarters Saint Joseph, United States
- Employees 74
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biozymeinc.com
- Social LinkedIn X
- Legal Name Biozyme Incorporated
- Latest Funding Round$107.44K (USD), Grant
Aug 2009
- Investors
- Employee Count74
Products & Services of BioZyme
BioZyme offers a comprehensive portfolio of products and services, including VitaFerm, Sure Champ, AO-Biotics, and Amaferm.
Nutritional supplement to boost cattle health and performance.
Supplements for show animals to support growth and vitality.
Products enhancing microbial balance in livestock digestion.
Fermentation-based additive for improving animal feed efficiency.
Funding Insights of BioZyme
- Total Rounds 2
- Last Round Grant — $107,442
- First Round $107,442
(Jul 2009)
- Investors Count 1
All 2 funding rounds of BioZyme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in BioZyme
BioZyme has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for BioZyme
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioZyme
12 people are tracked at BioZyme (3 in leadership, 9 in team); the tracked headcount is 74.
| Name | Role | Group |
|---|---|---|
Bob Norton | CEO & President | Leadership |
Lisa Norton | President and Chief Operating Officer | Leadership |
Sasha Tozzi | Vice President Of Operations | Leadership |
Maisie McClure | Brand Marketing Coordinator | Team |
Lori Lawrence | Senior Manager Of Supplement Marketing/senior Manager Of Commerical Marketing | Team |
Kevin Glaubius | Area Sales Manager | Team |
Cody Moreels | Operational Development Fermentation Manager | Team |
Jack Deshon | Cost Accountant | Team |
Angie Ruffoni | Marketing Brand Manager | Team |
Jessica McKinzie | Laboratory Technician | Team |
Chris Kyle | Sales Representative | Team |
Corey Hudson | Vitaferm Sales Representative/dealer | Team |
Complete people profiles for BioZyme
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioZyme
3 dated milestones of BioZyme across 58 years, from founding to its latest funding, stage changes and deals.
- Founded BioZyme is founded.
- Funding First funding round of $107K.
- Funding Latest funding round, Grant, of $107K.
Competitors of BioZyme
BioZyme has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of BioZyme
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioZyme
The website of BioZyme (biozymeinc.com) receives about 6.3K visits a month.
- Monthly visits6.3K
▲ 50.8% vs previous month
Websites whose visitors overlap most with BioZyme. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biostadt.com | 100% | 4.7K | #4,131,039 | View details | |
mekarn.org | mekarn.org | 88% | – | ||
vitaferm.com | vitaferm.com | 84% | #2,461,845 | – | |
nationalswine.com | nationalswine.com | 84% | #1,892,430 | – | |
| hctgroup.com | 24% | 8.4K | #2,604,541 | View details |
Top companies in Veterinary Healthcare & Products
3 companies that operate in the same segment as BioZyme (Veterinary Healthcare & Products) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
A chain of veterinary hospitals is operated nationwide. | 1986 | Los Angeles, California, United States | USD 5.96 B | 29,000 | ||
Chain of veterinary hospital | 2012 | Westport, United States | ||||
Diagnostics and pharmaceuticals for companion animals are developed. | 2015 | Ann Arbor, Michigan, United States | USD 32.03 M | 152 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biozyme
Complete news archive for BioZyme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioZyme
BioZyme was founded in 1951 and raised its 1st funding round 58 years after it was founded.
BioZyme is headquartered in Saint Joseph, United States. It is registered at Saint Joseph, Missouri, United States.
Bob Norton is the CEO of BioZyme, as recorded in our data.
BioZyme has 74 employees.
BioZyme was founded in 1951 in Saint Joseph, United States, and operates within the animal nutrition sector. Prebiotics and postbiotics are developed and produced from a proprietary strain of Aspergillus oryzae to support digestion, gut health, and well-being in cattle, swine, poultry, and companion animals. Additional feed additives are provided to improve overall nutrition. Research and development efforts are focused on product efficacy and validation of health benefits.
BioZyme's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.
BioZyme offers VitaFerm, Sure Champ, AO-Biotics, and Amaferm.
BioZyme has 1 investor. Key investors include HHS.
BioZyme operates through Biozyme Incorporated.